Medical termination of pregnancy in cynomolgus macaques

Journal of Medical Primatology

Volumn 41, Issue 6, 2012, Pages 394-402

  Micks, Elizabeth ^a   Shekell, Taylor ^b   Stanley, Jessica ^c   Zelinski, Mary ^c   Martin, Lauren ^c   Riefenberg, Serena ^c   Adevai, Tiffany ^c   Jensen, Jeffrey ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Contraception; Medical termination of pregnancy; Methotrexate; Mifepristone; Misoprostol

Indexed keywords

METHOTREXATE; MIFEPRISTONE; MISOPROSTOL;

ANIMAL EXPERIMENT; APPETITE DISORDER; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEHYDRATION; DESCRIPTIVE RESEARCH; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; MACACA; NONHUMAN; PAIN; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT FAILURE; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ANIMALS; FEMALE; GESTATIONAL AGE; MACACA FASCICULARIS; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; TREATMENT OUTCOME;

ANIMALIA; MACACA; MACACA FASCICULARIS; PRIMATES;

EID: 84868700012     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12019     Document Type: Article

References (23)

1. Barnhart K, Coutifaris C, Esposito M: The pharmacology of methotrexate. Expert Opin Pharmacother 2001; 2:409-17.
2. Bartz D, Goldberg A: Medication abortion. Clin Obstet Gynecol 2009; 52:140-50.
3. Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C: Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998; 57:83-8.
4. Chellman GJ, Bussiere JL, Makori N, Martin PL, Ooshima Y, Weinbauer GF: Developmental and reproductive toxicology studies in nonhuman primates. Birth Defects Res B Dev Reprod Toxicol 2009; 86:446-62.
5. Creinin MD, Krohn MA: Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion. Am J Obstet Gynecol 1997; 177:1444-9.
6. Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA: Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 2007; 109:885-94.
7. Heikinheimo O: Clinical pharmacokinetics of mifepristone. Clin Pharmacokinet 1997; 33:7-17.
8. Im A, Appleman LJ: Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology. Expert Opin Pharmacother 2010; 11:481-8.
9. Jensen JT, Stouffer RL, Stanley JE, Zelinski MB: Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials. Contraception 2010; 81:165-71.
10. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A: Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004; CD002855.
11. Larner JM, Reel JR, Blye RP: Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration. Hum Reprod 2000; 15:1100-6.
12. Nayak NR, Ghosh D, Lasley BL, Sengupta J: Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey. Contraception 1997; 55:103-14.
13. Owiti GE, Tarantal AF, Lasley BL, Hendrickx AG: The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis). Contraception 1989; 40:201-11.
14. Sarkar NN: Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur J Obstet Gynecol Reprod Biol 2002; 101:113-20.
15. Spitz IM, Bardin CW, Benton L, Robbins A: Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338:1241-7.
16. Tang OS, Gemzell-Danielsson K, Ho PC: Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007; 99(Suppl 2):S160-7.
17. Tarantal AF, Hendrickx AG, Matlin SA, Lasley BL, Gu QQ, Thomas CA, Vince PM, Van Look PF: Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis). Contraception 1996; 54:107-15.
18. Timmermans PJ, Schouten WG, Krijnen JC: Reproduction of cynomolgus monkeys (Macaca fascicularis) in harems. Lab Anim 1981; 15:119-23.
19. Weinbauer GF, Niehoff M, Niehaus M, Srivastav S, Fuchs A, Van Esch E, Cline JM: Physiology and endocrinology of the ovarian cycle in macaques. Toxicol Pathol 2008; 36:7S-23S.
20. Wilks JW: Pregnancy interception with a combination of prostaglandins: studies in monkeys. Science 1983; 221:1407-9.
21. Wilks JW: Interruption of early pregnancy in the monkey with mestranol and 5-oxa-17-phenyl-18, 19, 20-trinor prostaglandin F1 alpha methyl ester. Biol Reprod 1984; 30:886-93.
22. Wilson JG, Scott WJ, Ritter EJ, Fradkin R: Comparative distribution and embryotoxicity of methotrexate in pregnant rats and rhesus monkeys. Teratology 1979; 19:71-9.
23. Wolfgang MJ, Eisele SG, Knowles L, Browne MA, Schotzko ML, Golos TG: Pregnancy and live birth from nonsurgical transfer of in vivo- and in vitro-produced blastocysts in the rhesus monkey. J Med Primatol 2001; 30:148-55.